The store will not work correctly when cookies are disabled.
2-((5-bromo-2-((4-bromophenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide
ID: ALA4753666
PubChem CID: 162653455
Max Phase: Preclinical
Molecular Formula: C18H14Br2N4O2
Molecular Weight: 478.14
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNC(=O)c1ccccc1Oc1nc(Nc2ccc(Br)cc2)ncc1Br
Standard InChI: InChI=1S/C18H14Br2N4O2/c1-21-16(25)13-4-2-3-5-15(13)26-17-14(20)10-22-18(24-17)23-12-8-6-11(19)7-9-12/h2-10H,1H3,(H,21,25)(H,22,23,24)
Standard InChI Key: BPZWPAWJEQYPJP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.4749 -2.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4738 -3.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1818 -3.8947 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1800 -2.2573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8887 -2.6626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8875 -3.4877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5976 -3.8991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5999 -2.2487 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
5.3146 -2.6646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3133 -3.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0226 -3.8955 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7337 -3.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7310 -2.6612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0211 -2.2551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4420 -3.8930 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1491 -3.4834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1815 -4.7118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4737 -5.1202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8891 -5.1207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4734 -5.9374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8559 -3.8956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5626 -3.4867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5619 -2.6686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8486 -2.2612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1449 -2.6725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2684 -2.2581 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
3 17 1 0
17 18 1 0
17 19 2 0
18 20 1 0
16 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 16 1 0
23 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 478.14 | Molecular Weight (Monoisotopic): 475.9483 | AlogP: 4.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 76.14 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.70 | CX Basic pKa: 1.52 | CX LogP: 4.88 | CX LogD: 4.88 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -1.38 |
References
1. Sun D,Yang Z,Zhen Y,Yang Y,Chen Y,Yuan Y,Zhang L,Zeng X,Chen L. (2020) Discovery of 5-bromo-4-phenoxy-N-phenylpyrimidin-2-amine derivatives as novel ULK1 inhibitors that block autophagy and induce apoptosis in non-small cell lung cancer., 208 [PMID:32961380] [10.1016/j.ejmech.2020.112782] |